Pharmaron (03759.HK): Shareholders' Reduction Plan Completed, Total Reduction of 1.50%

NewTimespace.com reports, Pharmaron Beijing Co., Ltd. (Stock Code: 3759) announced that the share reduction plan of Shenzhen Xinzhong Kangcheng Investment Partnership (Limited Partnership) and its concert party Shenzhen Xinzhong Longcheng Investment Partnership (Limited Partnership), both shareholders holding more than 5% of the company's shares, has been completed. Xinzhong Kangcheng reduced its holdings by 9,242,600 shares through block trading at an average price of RMB29.67 per share, and by 7,600,000 shares through centralized competitive bidding at an average price of RMB26.59 per share. Xinzhong Longcheng reduced its holdings by 10,716,600 shares through centralized competitive bidding at an average price of RMB23.00 per share. The total reduction was 27,559,200 shares, representing 1.50% of the company's total share capital. Following the reduction, Xinzhong Kangcheng holds 197,754,700 shares, representing 10.76% of the total share capital, while Xinzhong Longcheng no longer holds any shares. The reduction was conducted in strict compliance with applicable laws and regulations and will not result in any change of control or adverse impact on corporate governance and ongoing operations.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.